NASDAQ:NOVT - Novanta Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$65.85 +0.70 (+1.07 %)
(As of 07/17/2018 04:00 PM ET)
Previous Close$65.15
Today's Range$64.90 - $66.00
52-Week Range$36.05 - $68.00
Volume122,200 shs
Average Volume220,985 shs
Market Capitalization$2.28 billion
P/E Ratio41.16
Dividend YieldN/A
Beta1.5
Novanta logoNovanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. Its Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; surgical displays and operating room integration technologies; optical data collection and machine vision technologies; radio frequency identification technologies; thermal printers; spectrometry technologies; and embedded touch screen solutions. The company's Precision Motion segment offers optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, ExoTec Precision, Synrad, Laser Quantum, WOM, Lemke, NDS, NDSsi, Reach Technology, JADAK, Skyetek, ThingMagic, Photo Research, General Scanning, Celera Motion, MicroE, Applimotion, and Westwind brands. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

Receive NOVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NOVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:NOVT
CUSIPN/A
Phone781-266-5618

Debt

Debt-to-Equity Ratio0.70
Current Ratio3.25
Quick Ratio2.18

Price-To-Earnings

Trailing P/E Ratio41.16
Forward P/E Ratio33.09
P/E GrowthN/A

Sales & Book Value

Annual Sales$521.29 million
Price / Sales4.38
Cash Flow$2.5307 per share
Price / Cash26.02
Book Value$9.01 per share
Price / Book7.31

Profitability

EPS (Most Recent Fiscal Year)$1.60
Net Income$60.05 million
Net Margins5.14%
Return on Equity20.02%
Return on Assets9.12%

Miscellaneous

Employees2,034
Outstanding Shares34,700,000
Market Cap$2,276.12

The Truth About Cryptocurrencies

Novanta (NASDAQ:NOVT) Frequently Asked Questions

What is Novanta's stock symbol?

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

How were Novanta's earnings last quarter?

Novanta Inc (NASDAQ:NOVT) posted its quarterly earnings data on Tuesday, May, 8th. The technology company reported $0.47 EPS for the quarter, topping the Zacks' consensus estimate of $0.40 by $0.07. The technology company had revenue of $147 million for the quarter, compared to analyst estimates of $139.55 million. Novanta had a return on equity of 20.02% and a net margin of 5.14%. The firm's quarterly revenue was up 34.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.31 earnings per share. View Novanta's Earnings History.

When is Novanta's next earnings date?

Novanta is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Novanta.

What guidance has Novanta issued on next quarter's earnings?

Novanta updated its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share guidance of $1.93 to $2.02 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.89. The company issued revenue guidance of $590-605 million, compared to the consensus revenue estimate of $592.91 million.Novanta also updated its Q2 guidance to $0.47-0.50 EPS.

What price target have analysts set for NOVT?

2 Wall Street analysts have issued 1 year price targets for Novanta's shares. Their forecasts range from $54.00 to $54.00. On average, they anticipate Novanta's share price to reach $54.00 in the next twelve months. This suggests that the stock has a possible downside of 18.0%. View Analyst Ratings for Novanta.

What is the consensus analysts' recommendation for Novanta?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Novanta's key competitors?

Who are Novanta's key executives?

Novanta's management team includes the folowing people:
  • Mr. Matthijs Glastra, CEO & Director (Age 49)
  • Mr. Robert J. Buckley, Chief Financial Officer (Age 44)
  • Mr. Brian S. Young, Chief HR Officer (Age 49)
  • Mr. Peter L. Chang, VP, Corp. Controller & Chief Accounting Officer (Age 53)
  • Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery

Has Novanta been receiving favorable news coverage?

Media stories about NOVT stock have trended positive on Tuesday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Novanta earned a coverage optimism score of 0.32 on Accern's scale. They also assigned news stories about the technology company an impact score of 45.75 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are Novanta's major shareholders?

Novanta's stock is owned by many different of institutional and retail investors. Top institutional shareholders include KAMES CAPITAL plc (1.44%) and Empowered Funds LLC (0.07%). Company insiders that own Novanta stock include Peter L Chang, Robert Buckley and Stephen W Bershad. View Institutional Ownership Trends for Novanta.

Which major investors are buying Novanta stock?

NOVT stock was purchased by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc and Empowered Funds LLC. View Insider Buying and Selling for Novanta.

How do I buy shares of Novanta?

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Novanta's stock price today?

One share of NOVT stock can currently be purchased for approximately $65.85.

How big of a company is Novanta?

Novanta has a market capitalization of $2.28 billion and generates $521.29 million in revenue each year. The technology company earns $60.05 million in net income (profit) each year or $1.60 on an earnings per share basis. Novanta employs 2,034 workers across the globe.

How can I contact Novanta?

Novanta's mailing address is 125 MIDDLESEX TURNPIKE, BEDFORD MA, 01730. The technology company can be reached via phone at 781-266-5618 or via email at [email protected]


MarketBeat Community Rating for Novanta (NASDAQ NOVT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  191
MarketBeat's community ratings are surveys of what our community members think about Novanta and other stocks. Vote "Outperform" if you believe NOVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.